Purdue Pharma L.P. Receives Patent for Rainbow Dynamic Dissolution Monitor(TM) System

Apr 03, 2001, 01:00 ET from Purdue Pharma L.P.

    STAMFORD, Conn., April 3 /PRNewswire/ -- Purdue Pharma today announced
 that it has received a patent covering fiber optic technology applied in the
 Rainbow Dynamic Dissolution Monitor(TM) System, a GMP compliant instrument for
 fiber optic analysis in dissolution testing of pharmaceutical dosage forms.
 Delphian Technology L.P. has a license to manufacture and market the system.
     The Rainbow Dynamic Dissolution Montior(TM) System operates "in situ,"
 providing real-time readings of therapeutic release levels and works with all
 oral dosage forms.  The unique "in situ" approach dramatically increases
 measurement frequency -- typically every ten minutes, but can be performed as
 fast as every 10 seconds.  The system simplifies the entire procedure,
 dramatically reduces time-to-completion and generates no chemical waste -- all
 while lowering material costs.
     The system includes a central multi-path spectrometer with fiber optic
 probes that remain resident in a dissolution vessel throughout its entire run.
 In actual use, the system resides on a lab bench, adjacent to one or more
 dissolution units.  The new monitor system can support six individual vessels
 simultaneously.  The monitor system supports most commercial dissolution
 units, including VanKel, Distek and Hanson.
 
     About Delphian Technology L.P.
     Delphian Technology L.P. is a developer and marketer of high quality
 analytical instruments for the pharmaceutical industry.  Its offices and
 laboratories are located in Ardsley, NY.  Visit the Delphian Technology web
 site at http://www.delphian-tech.com.
 
 

SOURCE Purdue Pharma L.P.
    STAMFORD, Conn., April 3 /PRNewswire/ -- Purdue Pharma today announced
 that it has received a patent covering fiber optic technology applied in the
 Rainbow Dynamic Dissolution Monitor(TM) System, a GMP compliant instrument for
 fiber optic analysis in dissolution testing of pharmaceutical dosage forms.
 Delphian Technology L.P. has a license to manufacture and market the system.
     The Rainbow Dynamic Dissolution Montior(TM) System operates "in situ,"
 providing real-time readings of therapeutic release levels and works with all
 oral dosage forms.  The unique "in situ" approach dramatically increases
 measurement frequency -- typically every ten minutes, but can be performed as
 fast as every 10 seconds.  The system simplifies the entire procedure,
 dramatically reduces time-to-completion and generates no chemical waste -- all
 while lowering material costs.
     The system includes a central multi-path spectrometer with fiber optic
 probes that remain resident in a dissolution vessel throughout its entire run.
 In actual use, the system resides on a lab bench, adjacent to one or more
 dissolution units.  The new monitor system can support six individual vessels
 simultaneously.  The monitor system supports most commercial dissolution
 units, including VanKel, Distek and Hanson.
 
     About Delphian Technology L.P.
     Delphian Technology L.P. is a developer and marketer of high quality
 analytical instruments for the pharmaceutical industry.  Its offices and
 laboratories are located in Ardsley, NY.  Visit the Delphian Technology web
 site at http://www.delphian-tech.com.
 
 SOURCE  Purdue Pharma L.P.